Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
by Ashok Venkitaraman, MBBS, PhD Singapore will hold its 15th Frontiers in Cancer Science (FCS) conference November 6-8 at...
AACR is a pioneer in the study of racial/ethnic and other disparities in cancer research and care. The 16th...
Centuries ago, when several Native tribes in northeastern America were at constant war, a peacemaker came to stop the...
In the beginning of his cancer journey, Edward Cutler felt unlucky. In 2012, he saw an ad suggesting that...
As the temperatures start to drop and the leaves begin to change color, enjoy the latest selection of studies...
As hundreds of cancer researchers and patient advocates traveled to Florida for the 16th AACR Conference on the Science...
Renowned prostate cancer researcher Folakemi T. Odedina, PhD, took the stage at the AACR Conference on the Science of...
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
Based on estimates from the National Cancer Institute, in 2023, more than 110,000 cases of gynecologic cancers are expected...
Courtney Addison is eternally grateful for the CAR T-cell therapy that sent her son Cayden’s leukemia into remission. But...